Clinical Trial Update: Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating cytokine-induced killer cells for metastatic urogenital tumors (bladder and renal cancer) is ongoing but with unknown stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Cytokine-induced killer cells

Snippet

Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Conditions: Bladder Cancer, Renal Cancer | Phase 1, Phase 2 | Status: UNKNOWN